STIM

Neuronetics Inc

Apr 09 • 12:23PM ET

1.41

-0.10 -6.62 %

Healthcare • Medical Devices • USA • NASD

Peers: COHR NOVA NVCR GNFT XFOR XERS SENS BLDR CANF

| Held by: VTI IWM PSIL VXF IWO VTWO IWC QQQS VTWG RSSL

Index	RUT	P/E	-	EPS (ttm)	-0.60	Insider Own	48.22%	Shs Outstand	68.99M	Perf Week	-5.37%
Market Cap	97.68M	Forward P/E	-	EPS next Y	-0.32	Insider Trans	8.47%	Shs Float	35.87M	Perf Month	15.57%
Enterprise Value	157.71M	PEG	-	EPS next Q	-0.17	Inst Own	34.58%	Short Float	26.09%	Perf Quarter	-22.10%
Income	-39.00M	P/S	0.65	EPS this Y	19.41%	Inst Trans	6.74%	Short Ratio	4.21	Perf Half Y	-51.55%
Sales	149.16M	P/B	4.35	EPS next Y	32.82%	ROA	-27.61%	Short Interest	9.36M	Perf YTD	2.17%
Book/sh	0.32	P/C	2.86	EPS next 5Y	32.68%	ROE	-155.73%	52W High	4.85 -70.92%	Perf Year	-65.44%
Cash/sh	0.49	P/FCF	-	EPS past 3/5Y	24.64% 16.51%	ROIC	-36.41%	52W Low	0.80 76.25%	Perf 3Y	-39.22%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	31.76% 24.81%	Gross Margin	46.40%	Volatility	16.07% 15.91%	Perf 5Y	-88.98%
Dividend TTM	-	EV/Sales	1.06	EPS Y/Y TTM	56.27%	Oper. Margin	-21.08%	ATR (14)	0.20	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	1.87	Sales Y/Y TTM	99.17%	Profit Margin	-26.15%	RSI (14)	48.34	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	2.02	EPS Q/Q	68.60%	SMA20	-1.16%	Beta	0.95	Target Price	4.33
Payout	-	Debt/Eq	4.03	Sales Q/Q	85.73%	SMA50	-4.20%	Rel Volume	0.85	Prev Close	1.51
Employees	658	LT Debt/Eq	3.79	Earnings	Mar 17 BMO	SMA200	-41.80%	Avg Volume	2.23M	Price	1.41
IPO	Jun 28, 2018	Option/Short	Yes / Yes	EPS/Sales Surpr.	5.21% 2.72%	Trades		Volume	891,054	Change	-6.62%

Date	Action	Analyst	Rating Change	Price Target Change
Aug-13-24	Downgrade	William Blair	Outperform → Mkt Perform
Oct-13-21	Downgrade	William Blair	Outperform → Mkt Perform
Oct-13-21	Downgrade	BTIG Research	Buy → Neutral
Jan-22-21	Upgrade	William Blair	Mkt Perform → Outperform
Feb-06-20	Initiated	BTIG Research	Buy	$11
Jul-24-18	Initiated	Canaccord Genuity	Buy

Apr-07-26 07:00AM	Neuronetics Comments on Letter from Pointillist Family Office (GlobeNewswire) -10.23%
Apr-06-26 04:30PM	Neuronetics Announces Chief Financial Officer Transition (GlobeNewswire) +15.79%
04:05PM	Largest Independent Shareholder of Neuronetics, Inc., Jorey Chernett, Calls for Immediate and Comprehensive Review of Strategic Alternatives, Including Sale of TMS Business (PR Newswire)
Mar-17-26 12:46PM	Neuronetics, Inc. Q4 2025 Earnings Call Summary (Moby) -9.93%
08:17AM	Neuronetics: Q4 Earnings Snapshot (Associated Press Finance)
07:50AM	Loading…
07:50AM	Neuronetics Reports Fourth Quarter and Full Year 2025 Financial and Operating Results (GlobeNewswire)
07:45AM	Neuronetics Appoints Dan Reuvers as President and Chief Executive Officer (GlobeNewswire)
Mar-03-26 08:30AM	Neuronetics to Report Fourth Quarter 2025 Financial and Operating Results and Host Conference Call (GlobeNewswire)
Feb-11-26 12:20AM	Neuronetics (STIM) Stock Rises 41% After Hours: What's Going On? (Benzinga) +23.29%
Feb-10-26 04:34PM	Neuronetics Announces Selected Preliminary Unaudited Fourth Quarter and Full Year 2025 Financial Results (GlobeNewswire)
Nov-20-25 08:30AM	Neuronetics to Participate at the Piper Sandler 37th Annual Healthcare Conference (GlobeNewswire) -12.75%
Nov-12-25 10:33AM	TRICARE West Expands NeuroStar TMS Coverage to Include Adolescents Aged 15+ Struggling with Depression (GlobeNewswire)
Nov-04-25 04:08PM	Neuronetics Inc (STIM) Q3 2025 Earnings Call Highlights: Revenue Surges Amid Strategic Acquisitions (GuruFocus.com)
08:40AM	Neuronetics (STIM) Reports Q3 Loss, Misses Revenue Estimates (Zacks)
07:39AM	Neuronetics: Q3 Earnings Snapshot (Associated Press Finance)
07:05AM	Loading…
07:05AM	Neuronetics Reports Third Quarter 2025 Financial and Operating Results and Announces CEO Transition Plan (GlobeNewswire)
Nov-03-25 08:09AM	Neuronetics Inc (STIM) Q3 2025: Everything You Need To Know Ahead Of Earnings (GuruFocus.com)
Oct-31-25 04:30PM	Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
Oct-30-25 08:32AM	Neuronetics Announces Three-Year Exclusive Partnership with Elite DNA Behavioral Health to Expand NeuroStar Access and Operational Excellence (GlobeNewswire) -6.90%
Oct-21-25 08:30AM	Neuronetics to Report Third Quarter 2025 Financial and Operating Results and Host Conference Call (GlobeNewswire) +5.49%
Sep-17-25 08:32AM	New York State Medicaid Expands Coverage for TMS Therapy, Including NeuroStar Advanced Therapy, to Treat Major Depressive Disorder (MDD) (GlobeNewswire)
Sep-02-25 03:49AM	Neuronetics, Inc. (STIM) Positions as Neurohealth Leader with Adolescent Breakthrough (Insider Monkey) -5.71%
Aug-06-25 04:45PM	Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire) -6.60% -5.65%
Aug-05-25 08:20AM	Neuronetics (STIM) Reports Q2 Loss, Tops Revenue Estimates (Zacks)
07:19AM	Neuronetics: Q2 Earnings Snapshot (Associated Press Finance)
07:05AM	Neuronetics Reports Second Quarter 2025 Financial and Operating Results (GlobeNewswire)
Aug-04-25 04:30PM	Neuronetics to Present at the Canaccord Genuity 45th Annual Growth Conference (GlobeNewswire) +5.43%
10:04AM	What To Expect From Neuronetics Inc (STIM) Q2 2025 Earnings (GuruFocus.com)
Jul-30-25 08:32AM	NeuroStar Announces New Publication in JAACAP Open Highlighting Treatment Efficacy in Depressed Adolescents (GlobeNewswire)
Jul-22-25 08:30AM	Neuronetics to Report Second Quarter 2025 Financial and Operating Results and Host Conference Call (GlobeNewswire) +8.76%
07:30AM	Loading…
Jul-15-25 07:30AM	Neuronetics Appoints New Chief Financial Officer (GlobeNewswire)
Jul-09-25 07:20AM	Neuronetics Showcases NeuroStar TMS Data at Clinical TMS Meeting (Insider Monkey)
Jun-19-25 07:00PM	Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
Jun-10-25 08:31AM	Neuronetics Announces Clinical Presence at the 2025 Clinical TMS Society Annual Meeting and Progress in Greenbrook's Personalized Care Trial Program (GlobeNewswire)
Jun-02-25 04:30PM	Neuronetics Set to Join Russell 2000 and Russell 3000 Indexes (GlobeNewswire)
May-14-25 08:31AM	Neuronetics Launches First Inaugural National TMS Therapy Awareness Day During Mental Health Awareness Month (GlobeNewswire)
May-07-25 03:09AM	Neuronetics Inc (STIM) Q1 2025 Earnings Call Highlights: Revenue Surge Amidst Margin Challenges (GuruFocus.com)
May-06-25 08:20AM	Neuronetics (STIM) Reports Q1 Loss, Tops Revenue Estimates (Zacks)
07:20AM	Neuronetics: Q1 Earnings Snapshot (Associated Press Finance)
07:10AM	Neuronetics Reports First Quarter 2025 Financial and Operating Results (GlobeNewswire)
May-05-25 04:30PM	Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
07:40AM	Integra LifeSciences (IART) Q1 Earnings Miss Estimates (Zacks)
Apr-30-25 05:50AM	Why Neuronetics, Inc. (STIM) is Surging in 2025 (Insider Monkey)
Apr-22-25 08:30AM	Neuronetics to Report First Quarter 2025 Financial and Operating Results and Host Conference Call (GlobeNewswire)
Apr-02-25 03:26PM	BrainsWay: Strong Growth Prospects Matter Little To The Market (Seeking Alpha)
Mar-31-25 08:31AM	Evernorth Health Services, a Cigna Company, Expands NeuroStar TMS Coverage for Adolescents Struggling with Depression (GlobeNewswire)
Mar-29-25 11:45PM	Neuronetics: Explosive Growth Poised To Soar On FDA Breakthroughs (Seeking Alpha)
Mar-27-25 04:30PM	Neuronetics Reports Updated Fourth Quarter and Full Year 2024 Financial and Operating Results (GlobeNewswire) -5.75%
Mar-18-25 09:55AM	Wall Street Analysts Think Neuronetics (STIM) Could Surge 34.98%: Read This Before Placing a Bet (Zacks)
Mar-05-25 02:06AM	Neuronetics Inc (STIM) Q4 2024 Earnings Call Highlights: Revenue Growth Amidst Rising Expenses ... (GuruFocus.com) +7.11%
Mar-04-25 11:29PM	Q4 2024 Neuronetics Inc Earnings Call (Thomson Reuters StreetEvents) +18.78%
07:36AM	Neuronetics: Q4 Earnings Snapshot (Associated Press Finance)
07:10AM	Neuronetics Reports Fourth Quarter and Full Year 2024 Financial and Operating Results (GlobeNewswire)
Mar-03-25 04:30PM	Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
07:20AM	Neuronetics Inc (STIM) Q4 2024 Earnings Report Preview: What To Look For (GuruFocus.com)
Feb-22-25 05:08PM	Neuronetics, Inc. (STIM): Among the Hot Penny Stocks to Buy Now (Insider Monkey)
Feb-21-25 08:30AM	Neuronetics to Report Fourth Quarter 2024 Financial and Operating Results and Host Conference Call (GlobeNewswire) -13.96%
Feb-07-25 04:30PM	Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire) -13.76% +25.73%
07:54AM	Neuronetics Announces Pricing of $18 Million Underwritten Public Offering of Common Stock (GlobeNewswire)
Feb-06-25 04:23PM	Neuronetics Announces Launch of Underwritten Public Offering of Common Stock (GlobeNewswire) +8.87%
Feb-03-25 07:27PM	Why Neuronetics Inc (STIM) Is Skyrocketing So Far In 2025 (Insider Monkey) +7.81%
Jan-29-25 08:31AM	NeuroStar Unveils Two Significant Publications on TMS Therapy for Depression (GlobeNewswire) +6.31%
Jan-13-25 08:00AM	Neuronetics Provides Business Update and Issues 2025 Guidance (GlobeNewswire) +36.84%
Dec-18-24 04:30PM	Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire) +5.38% -5.84%
Dec-16-24 04:30PM	Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire) +19.27%
Dec-10-24 10:00AM	Neuronetics and Greenbrook TMS Announce Closing of Transaction (GlobeNewswire)
Nov-20-24 08:30AM	Neuronetics to Present at the Piper Sandler 36th Annual Healthcare Conference (GlobeNewswire) +6.26%
Nov-13-24 02:10AM	Neuronetics Inc (STIM) Q3 2024 Earnings Call Highlights: Revenue Growth Amid Rising Expenses ... (GuruFocus.com) -11.65%
Nov-12-24 06:45PM	CORRECTION Neuronetics Reports Record Third Quarter 2024 Financial and Operating Results (GlobeNewswire) -37.27%
04:30PM	Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
08:20AM	Neuronetics (STIM) Reports Q3 Loss, Lags Revenue Estimates (Zacks)
07:19AM	Neuronetics: Q3 Earnings Snapshot (Associated Press Finance)
07:10AM	Neuronetics Reports Record Third Quarter 2024 Financial and Operating Results (GlobeNewswire)
Nov-11-24 07:26AM	Neuronetics Inc (STIM) Q3 2024 Earnings Report Preview: What to Expect (GuruFocus.com) -5.98%
Oct-29-24 04:30PM	Neuronetics to Report Third Quarter 2024 Financial and Operating Results and Host Conference Call (GlobeNewswire) +5.94%
Oct-14-24 08:31AM	NeuroStar Oral Presentation at AACAP 2024 Highlights Largest Study Evaluating TMS Efficacy in Adolescents with Depression (GlobeNewswire)
Oct-04-24 08:33AM	Neuronetics and Greenbrook TMS Announce Receipt of Interim Order in Respect of Proposed Arrangement and Provide Details of Shareholder Meetings (PR Newswire) +7.58%
Sep-25-24 08:31AM	Health Care Service Corporation Adds First-Line TMS Coverage for Adolescents (GlobeNewswire) -6.18%
Sep-19-24 08:31AM	Expanded Health Policies Enhance TMS Therapy Access for Adolescents and Adults (GlobeNewswire)
Sep-16-24 08:32AM	NeuroStar Releases Software Upgrades to Elevate Patient Care (GlobeNewswire) +6.70%
Sep-03-24 08:29AM	NeuroStar Honors Suicide Prevention Month With Milestone Achievement and Powerful Stories (GlobeNewswire)
Aug-20-24 08:29AM	NeuroStar Marks Two Years of Transformative Impact with NeuroStar University (GlobeNewswire)
Aug-15-24 05:42AM	Neuronetics inks Greenbrook merger to acquire treatment centers (MedTech Dive) +16.32%
Aug-13-24 12:56PM	Neuronetics' (STIM) Latest Deal to Aid Mental Health Treatments (Zacks)
12:47PM	Neuronetics (STIM) Inks a New Merger Agreement With Greenbrook (Zacks)
09:45AM	Neuronetics (STIM) Q2 Loss Wider Than Expected, Revenues Fall Y/Y (Zacks)
Aug-12-24 08:25AM	Neuronetics (STIM) Reports Q2 Loss, Lags Revenue Estimates (Zacks) -58.15%
07:19AM	Neuronetics: Q2 Earnings Snapshot (Associated Press Finance)
07:15AM	Neuronetics and Greenbrook TMS Announce Definitive Agreement to Merge (GlobeNewswire)
07:10AM	Neuronetics Reports Record Second Quarter 2024 Financial and Operating Results (GlobeNewswire)
Aug-05-24 04:36PM	Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
Aug-01-24 08:29AM	NeuroStar Partners With This Is My Brave to Recognize Teen Mental Health Month (GlobeNewswire)
Jul-31-24 08:30AM	Neuronetics to Present at the Canaccord Genuity 44th Annual Growth Conference (GlobeNewswire)
Jul-30-24 08:30AM	Neuronetics Announces the Closing of up to $90 Million Senior Secured Credit Facility with Perceptive Advisors (GlobeNewswire)
Jul-29-24 08:30AM	Neuronetics to Report Second Quarter 2024 Financial and Operating Results and Host Conference Call (GlobeNewswire)
Jul-22-24 08:31AM	Aetna Policy Update Expands TMS Availability for Adolescents With Depression (GlobeNewswire)
Jul-18-24 10:30AM	3 Neurotech Stocks Bridging Mind and Machine (InvestorPlace) -5.00%
Jul-11-24 12:53PM	TMS in California will have Medicaid coverage for major depressive disorder patients (Medical Device Network)
08:36AM	California Medicaid Adds TMS Access for 14.8 Million Adolescents and Adults (GlobeNewswire)
Jul-10-24 08:32AM	BlueCross BlueShield MI and Cambia Health Solutions Expand TMS Access for Depressed Adolescents (GlobeNewswire)

Neuronetics, Inc. is a commercial stage medical technology company, which focuses on designing, developing and marketing products that improve the quality of life for patients who suffer from neurohealth disorders. It operates through United States and International geographical segments. The company was founded by Steven B. Waite, Bruce J. Shook, Norman R. Weldon, and Thomas D. Weldon in 2003 and is headquartered in Malvern, PA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Chernett Jorey	10% Owner	Mar 30 '26	Buy	1.25	385,442	481,802	9,778,988	Mar 30 07:41 PM
Chernett Jorey	10% Owner	Mar 27 '26	Buy	1.35	500,000	675,000	9,393,276	Mar 30 09:37 AM
Chernett Jorey	10% Owner	Mar 25 '26	Buy	1.40	125,000	175,000	8,868,276	Mar 27 09:33 AM
Chernett Jorey	10% Owner	Mar 26 '26	Buy	1.44	25,000	36,000	8,893,276	Mar 27 09:33 AM
Pfanstiel Steven	EVP, CFO and Treasurer	Mar 19 '26	Sale	1.34	16,431	22,018	828,781	Mar 24 05:52 PM
Sullivan Keith J	Former Officer & Director	Mar 19 '26	Sale	1.34	46,289	62,027	1,590,924	Mar 24 05:50 PM
MACAN WILLIAM ANDREW	EVP, CLO and CS	Mar 19 '26	Sale	1.34	16,005	21,447	897,270	Mar 24 05:48 PM
Chernett Jorey	10% Owner	Mar 20 '26	Buy	1.41	169,472	238,956	8,743,276	Mar 23 09:34 AM
Chernett Jorey	10% Owner	Mar 18 '26	Buy	1.35	607,400	819,990	8,123,804	Mar 20 08:51 AM
Chernett Jorey	10% Owner	Mar 19 '26	Buy	1.33	450,000	598,500	8,573,804	Mar 20 08:51 AM
MACAN WILLIAM ANDREW	Officer	Mar 19 '26	Proposed Sale	1.32	16,005	21,123		Mar 19 04:36 PM
Sullivan Keith J	Officer	Mar 19 '26	Proposed Sale	1.32	46,289	61,092		Mar 19 04:25 PM
Chernett Jorey	10% Owner	Mar 17 '26	Buy	1.16	531,000	615,960	7,516,404	Mar 18 10:36 AM
MACAN WILLIAM ANDREW	EVP, CLO and CS	Mar 04 '26	Sale	1.34	609	816	879,525	Mar 06 04:29 PM
MACAN WILLIAM ANDREW	Officer	Mar 04 '26	Proposed Sale	1.34	609	814		Mar 04 03:09 PM
MACAN WILLIAM ANDREW	EVP, CLO and CS	Feb 26 '26	Sale	1.35	3,427	4,626	880,134	Feb 27 04:34 PM
Sullivan Keith J	President and CEO	Feb 26 '26	Sale	1.35	8,452	11,410	1,524,713	Feb 27 04:33 PM
Sullivan Keith J	Officer	Feb 26 '26	Proposed Sale	1.34	8,452	11,366		Feb 26 03:33 PM
MACAN WILLIAM ANDREW	Officer	Feb 26 '26	Proposed Sale	1.34	3,427	4,609		Feb 26 03:16 PM
Sullivan Keith J	President and CEO	Feb 12 '26	Sale	1.65	33,847	55,848	1,533,165	Feb 18 05:44 PM
MACAN WILLIAM ANDREW	EVP, CLO and CS	Feb 12 '26	Sale	1.65	14,120	23,298	673,561	Feb 18 05:42 PM
MACAN WILLIAM ANDREW	EVP, CLO and CS	Feb 10 '26	Sale	1.55	3,485	5,402	687,681	Feb 12 04:32 PM
Sullivan Keith J	President and CEO	Feb 10 '26	Sale	1.55	40,976	63,513	1,567,012	Feb 12 04:31 PM
Sullivan Keith J	Officer	Feb 12 '26	Proposed Sale	1.65	33,847	55,712		Feb 12 03:19 PM
MACAN WILLIAM ANDREW	Officer	Feb 12 '26	Proposed Sale	1.65	14,120	23,242		Feb 12 03:12 PM
MACAN WILLIAM ANDREW	Officer	Feb 10 '26	Proposed Sale	1.55	3,485	5,392		Feb 10 04:28 PM
Sullivan Keith J	Officer	Feb 10 '26	Proposed Sale	1.55	40,976	63,398		Feb 10 04:14 PM
Madryn Asset Management, LP	10% Owner	Aug 08 '25	Sale	3.72	3,500,000	13,020,000	1,142,351	Aug 12 04:15 PM
MADRYN HEALTH PRTS II (CAY MAS	10% Owner	Aug 08 '25	Proposed Sale	3.72	2,925,554	10,883,061		Aug 08 04:55 PM
MADRYN HEALTH PARTNERS II, LP	10% Owner	Aug 08 '25	Proposed Sale	3.72	192,806	717,238		Aug 08 04:54 PM
MADRYN SELECT OPPORTUNITIES, L	10% Owner	Aug 08 '25	Proposed Sale	3.72	381,640	1,419,701		Aug 08 04:54 PM
Furlong Stephen	Officer	Aug 07 '25	Proposed Sale	4.09	98,635	403,385		Aug 07 04:52 PM
Furlong Stephen	EVP, CFO and Treasurer	May 12 '25	Sale	4.27	193,460	826,074	416,593	May 14 05:05 PM
Furlong Stephen	EVP, CFO and Treasurer	May 13 '25	Sale	4.16	6,540	27,206	410,053	May 14 05:05 PM
Furlong Stephen	Officer	May 13 '25	Proposed Sale	4.16	6,540	27,190		May 13 12:54 PM
Furlong Stephen	Officer	May 12 '25	Proposed Sale	4.27	193,460	826,283		May 12 04:40 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

STIM

Neuronetics Inc

Upgrade your Finviz experience